Vanguard reports 5.51% stake in Acadia Healthcare
Acadia Healthcare Co Inc reports a Schedule 13G disclosure showing Vanguard Portfolio Management beneficially owns 5,079,563 shares of Common Stock, equal to 5.51% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Acadia Healthcare Co Inc reports a Schedule 13G disclosure showing Vanguard Portfolio Management beneficially owns 5,079,563 shares of Common Stock, equal to 5.51% of the class. The filing states Vanguard Portfolio Management has sole dispositive power over 5,079,563 shares and sole voting power over 18,125 shares. The disclosure is signed by Ashley Grim on 04/28/2026 and cites the portfolio management and affiliated Vanguard entities described in the release.
Insights
Vanguard holds a >5% passive stake with dispositive control over 5,079,563 shares.
Vanguard Portfolio Management reports beneficial ownership of 5,079,563 shares (5.51%) and sole dispositive power for the same amount. The filing attributes voting/dispositive arrangements to Vanguard affiliates and fund sleeves per SEC Release No. 34-39538.
Ownership above 5% requires disclosure and can be useful for tracking institutional concentration. Subsequent filings will show any material change in stake; timing of future changes is not provided in the excerpt.
Schedule 13G was filed under passive/investment manager context with affiliate disclosures.
The form lists the filer as Vanguard Portfolio Management and includes the SEC-release based attribution statement explaining holdings include Vanguard funds and managed accounts. The disclosure indicates no single external person holds >5% of these reported securities.
Signatory is Ashley Grim, Head of Global Fund Administration, dated 04/28/2026. This is a routine beneficial-ownership disclosure under applicable rules.
Key Figures
Key Terms
Schedule 13G regulatory
Beneficially owned financial
Dispositive power regulatory
SEC Release No. 34-39538 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Vanguard report in Acadia Healthcare (ACHC)?
When was the Schedule 13G for ACHC signed and who signed it?
Does the Vanguard filing identify other persons with >5% interest in ACHC?
Which Vanguard entities are referenced in the ACHC Schedule 13G?
AI-generated analysis. How Rhea-AI works. Not financial advice.